Earnings Alerts

Molina Healthcare (MOH) Earnings: Q1 Adjusted EPS Surpasses Expectations with Strong Revenue Growth

  • Molina’s first quarter adjusted earnings per share (EPS) were $6.08, surpassing both the previous year’s $5.73 and the estimated $5.96.
  • The company reported revenues of $11.15 billion, marking a 12% increase from the previous year, and exceeding the estimated $10.86 billion.
  • The medical care ratio rose slightly to 89.2%, compared to 88.5% in the previous year.
  • Investment analysts’ recommendations include 6 buys, 9 holds, and 2 sells.

Molina Healthcare on Smartkarma

Analysts on independent research network Smartkarma have been closely covering Molina Healthcare‘s recent financial performance and strategic moves. Baptista Research‘s report, “Molina Healthcare’s Medical Cost Crisis – How They’re Fighting Back!”, highlights the company’s mixed results in the fourth quarter and full year of 2024. Despite showing an 8.5% year-over-year growth in adjusted EPS, Molina Healthcare faced challenges due to higher medical costs in the Medicaid and Medicare segments, resulting in a consolidated medical care ratio (MCR) of 90.2% for the quarter.

In a separate analysis by Baptista Research titled “Molina Healthcare Inc.: These Are The 6 Biggest Factors Impacting Its Performance In 2025 & Beyond! – Major Drivers”, the focus is on Molina Healthcare‘s third-quarter earnings report of 2024. The report emphasizes the company’s balanced financial achievements and challenges, showcasing an adjusted pre-tax margin of 4.5% despite an 89.2% consolidated MCR. The insights from these reports provide investors with valuable perspectives on Molina Healthcare‘s position in the healthcare market.


A look at Molina Healthcare Smart Scores

FactorScoreMagnitude
Value2
Dividend1
Growth4
Resilience3
Momentum5
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

When looking at Molina Healthcare‘s future prospects through the lens of Smartkarma Smart Scores, the company appears to have a promising long-term outlook. With a strong score in Growth and Momentum, Molina Healthcare is positioned well for expansion and continued market success. This indicates that the company is likely to see positive developments in terms of business growth and stock performance over time.

Molina Healthcare, as a managed care organization that focuses on providing healthcare services to low-income families, shows resilience in navigating challenges, as reflected in its Resilience score. While there may be room for improvement in aspects like Value and Dividend, the company’s overall outlook seems positive, especially with its solid scores in Growth and Momentum. With a presence in multiple states and a network of primary care clinics, Molina Healthcare seems well-positioned for long-term success in the healthcare industry.

Summary of company:
Molina Healthcare Inc. is a managed care organization that facilitates the delivery of healthcare services to individuals eligible for Medicaid and other programs aimed at low-income families. Operating health plans in multiple states and running primary care clinics, Molina Healthcare is focused on providing essential healthcare services to those in need.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars